Nagasaka A, Hige S, Marutani M, Tsunematsu I, Saito M, Yamamoto Y, Konishi S, Asaka M
Third Department of Internal Medicine, Hokkaido University School of Medicine, Sapporo, Japan.
Dig Dis Sci. 1998 Nov;43(11):2473-8. doi: 10.1023/a:1026690400897.
We examined the frequency and significance of mutations in the core promoter and precore region in 103 Japanese patients with chronic hepatitis B virus (HBV) infection. HBV DNAs from the patients' sera were amplified by polymerase chain reaction and were directly sequenced. A double mutation (T1762 A1764) in the core promoter was frequently observed in the patients regardless of HBeAg status except for asymptomatic carriers with HBeAg. Furthermore, a mutation at nucleotide 1753 from T to C or G was frequently found in anti-HBe positive patients and was often accompanied by the double mutation. The A1896 mutation was found in only about one fourth of the patients with anti-HBe. These data suggest that the patients with chronic liver diseases frequently had a double mutation regardless of HBeAg status and a mutation at nucleotide 1753 might be associated with HBeAg-negative chronic hepatitis B virus infection.
我们检测了103例日本慢性乙型肝炎病毒(HBV)感染患者核心启动子和前核心区域突变的频率及意义。通过聚合酶链反应扩增患者血清中的HBV DNA并直接测序。除HBeAg阳性的无症状携带者外,无论HBeAg状态如何,患者中均频繁观察到核心启动子的双突变(T1762A1764)。此外,在抗HBe阳性患者中经常发现核苷酸1753处从T到C或G的突变,且常伴有双突变。仅约四分之一的抗HBe患者中发现了A1896突变。这些数据表明,无论HBeAg状态如何,慢性肝病患者常存在双突变,且核苷酸1753处的突变可能与HBeAg阴性的慢性乙型肝炎病毒感染有关。